Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Constance Baer"'
Autor:
Maki Sakuma, Constance Baer, Manja Meggendorfer, Claudia Haferlach, Wolfgang Kern, Torsten Haferlach, Wencke Walter
Publikováno v:
HemaSphere, Vol 7, p e3306813 (2023)
Externí odkaz:
https://doaj.org/article/b4697b70dd564aefb37a98080758afe1
Autor:
Maki Sakuma, Constance Baer, Manja Meggendorfer, Claudia Haferlach, Wolfgang Kern, Torsten Haferlach, Wencke Walter
Publikováno v:
HemaSphere, Vol 7, p e13393b9 (2023)
Externí odkaz:
https://doaj.org/article/43f67482789742e29efb38528c7cf6f7
Autor:
Sandra Huber, Constance Baer, Stephan Hutter, Frank Dicker, Manja Meggendorfer, Christian Pohlkamp, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach, Gregor Hoermann
Publikováno v:
HemaSphere, Vol 7, p e24060be (2023)
Externí odkaz:
https://doaj.org/article/82cc7151eff4472d9f10873f5a061acc
Autor:
Claudia Haferlach, Sandra Huber, Constance Baer, Stephan Hutter, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Gregor Hoermann
Publikováno v:
HemaSphere, Vol 7, p e635949f (2023)
Externí odkaz:
https://doaj.org/article/8512160d672a4fc4a231438cee907093
Autor:
Natalie Wossidlo, Sandra Huber, Torsten Haferlach, Manja Meggendorfer, Stephan Hutter, Gregor Hoermann, Isolde Summerer, Henning Ruge, Constance Baer, Wolfgang Kern, Claudia Haferlach
Publikováno v:
HemaSphere, Vol 7, p e9009360 (2023)
Externí odkaz:
https://doaj.org/article/dc1b655cd9734ff4a16625f0869f4e87
Publikováno v:
Haematologica, Vol 107, Iss 2 (2021)
Externí odkaz:
https://doaj.org/article/12a89b305da64020a456a775040dffea
Autor:
Constance Baer, Wencke Walter, Stephan Hutter, Sven Twardziok, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach
Publikováno v:
Haematologica, Vol 104, Iss 8 (2019)
Externí odkaz:
https://doaj.org/article/7935a13e250e4d1fb864dca0c09351fd
Publikováno v:
Haematologica, Vol 103, Iss 8 (2018)
Externí odkaz:
https://doaj.org/article/8d56dc1489e0418b864ea89d0c88afe9
Autor:
Constance Baer, Wolfgang Kern, Sarah Koch, Niroshan Nadarajah, Sonja Schindela, Manja Meggendorfer, Claudia Haferlach, Torsten Haferlach
Publikováno v:
Haematologica, Vol 101, Iss 7 (2016)
Chronic myeloid leukemia cells acquire resistance to tyrosine kinase inhibitors through mutations in the ABL1 kinase domain. The T315I mutation mediates resistance to imatinib, dasatinib, nilotinib and bosutinib, whereas sensitivity to ponatinib rema
Externí odkaz:
https://doaj.org/article/e27183783ece458f9da6ed2825a8c123